Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Nov 2022	43	Global Markets Direct	ASDR-613187

Published: Nov 2022 - Pages : 43 - Publisher : Global Markets Direct - Report code : ASDR-613187

AstraZeneca Plc
Bavarian Nordic AS
IDBiologics Inc
Sigmovir Biosystems Inc
Visterra Inc